Chrysos Corporation Ltd (ASX:C79) announces securing a AU$65 million loan from the Commonwealth Bank of Australia (CBA), augmenting its existing AU$30 million facility. With the additional funds, including the repayment of an AU$8 million balance, Chrysos' total debt availability reaches AU$95 million. This capital infusion supports general corporate needs and facilitates the production and deployment of new PhotonAssayTM units for the company's global expansion.
Dirk Treasure, Chrysos’ CEO, expresses gratitude for CBA's ongoing support, stating that the increased facility, coupled with operating cash flows and a recent AU$75 million capital raise, positions Chrysos favorably for building and deploying additional PhotonAssayTM units worldwide. The financing terms include a AU$20 million three-year term and a AU$45 million 4.5-year term. Chrysos Corporation, headquartered in Adelaide, specializes in mining technology solutions, with its flagship product PhotonAssayTM offering rapid and eco-friendly analysis of precious metals.
Customer Notice:
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
Kapitales Research, Level 13, Suite 1A, 465 Victoria Ave, Chatswood, NSW 2067, Australia | 1800 005 780 | info@kapitales.com
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 21, 2024
Nov 20, 2024
Nov 20, 2024
Nextgen Global Services Pty Ltd trading as Kapitales Research (ABN 89 652 632 561) is a Corporate Authorised Representative (CAR No. 1293674) of Enva Australia Pty Ltd (AFSL 424494). The information contained in this website is general information only. Any advice is general advice only. No consideration has been given or will be given to the individual investment objectives, financial situation or needs of any particular person. The decision to invest or trade and the method selected is a personal decision and involves an inherent level of risk, and you must undertake your own investigations and obtain your own advice regarding the suitability of this product for your circumstances. Please be aware that all trading activity is subject to both profit & loss and may not be suitable for you. The past performance of this product is not and should not be taken as an indication of future performance.
